Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: COPD Interventions: Drug: RPL554 suspension; Drug: Placebo Sponsor: Verona Pharma plc Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials